Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • SuzuBell
    Member
    • Nov 2013
    • 22

    #1

    Example RNA-seq datasets with low and high false-positive rates

    Hello,

    I am trying to obtain two example RNA-seq datasets. One has verified low false positive rate, and the other has verified high false positive rate.

    Specifically, I am hoping to obtain 3 things for each dataset:

    1) The processed count table (filtered, normalized, and whatever else) that was directly fed into the model that created the DEG list.

    2) The DEG list (simply which rows of the count table were designated DEGs)

    3) An estimated false positive rate (or similar metric) showing how reliable the DEG list is. Maybe from some golden standard type of procedure. For one dataset, this rate is high. For the other dataset, this rate is low.

    If I need the processed count table and DEG list myself that is of course fine too. I am just hoping it is clear and reproducible documentation.

    I would be very grateful to hear from anyone who has knowledge even of just one of these datasets too. Thank you for any input!
  • GenoMax
    Senior Member
    • Feb 2008
    • 7142

    #2
    You could simulate them yourself to have precise control over the "truth".

    Comment

    • SuzuBell
      Member
      • Nov 2013
      • 22

      #3
      Thank you, I am trying to use real (not simulated) RNA-seq data.

      Comment

      • GenoMax
        Senior Member
        • Feb 2008
        • 7142

        #4
        You will find plenty of real datasets which will (claim to have) low false positive rates (everyone wants to achieve that) but it may be hard to find a real dataset that has high false positive rate (since no reviewer would accept that).

        Comment

        • SuzuBell
          Member
          • Nov 2013
          • 22

          #5
          Thanks GenoMax.

          1) I agree it might be hard to find a high false-positive rate example on its own. However, if that is the case, I am hoping to find an easily-reproducible example of a dataset that, say, has high false-positive rate when analyzed one way, but low false-positive rate when analyzed another way. This might be available in studies promoting a certain methodology. I am very interested in seeing what DEGs looks like (by counts) when they come from established high false positive rate.

          2) I do have one dataset that returns a suspiciously large number of DEGs (through edgeR, DESeq, and limmaVoom). However, when I look at the DEGs (view their counts), I do not see much larger variation between treatment groups than between replicates as expected. This makes me *suspect* many of these DEGs are false positive calls. However, I am looking for a dataset which has been compared to some *standard* that shows it indeed has a high false positive rate, and unfortunately, I do not know of a way to do that with my data. Hence, I am trying to find a public dataset.

          Comment

          • Dario1984
            Senior Member
            • Jun 2011
            • 166

            #6
            RNA-seq differential expression methods are known to be affected by outliers. You have used edgeR to analyse the dataset. What dispersion estimation variety did you use? If you have patient replicates, you should use the robust variety of dispersion estimation. The default method is only useful if you are analysing replicates of cell lines (e.g. 3 replicates of PrEC and 3 replicates of LNCaP), which aren't representative of biological tissue and the heterogeneity of it. There's also a robust style of limma analysis you could be using.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
              by SEQadmin2



              Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

              Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
              ...
              10-14-2026, 09:55 AM
            • SEQadmin2
              New Genomics Technologies Take Aim at Long-Standing Limits
              by SEQadmin2


              Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

              We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
              ...
              09-28-2026, 10:25 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 10-22-2026, 11:13 AM
            0 responses
            30 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-22-2026, 10:48 AM
            0 responses
            22 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-15-2026, 10:52 AM
            0 responses
            39 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 10-14-2026, 05:39 AM
            0 responses
            45 views
            0 reactions
            Last Post SEQadmin2  
            Working...